|
|
||||||||


*
Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109;
Department of Surgery, University of Louisville School of Medicine, Louisville, KY 40202; and
Department of Drug Safety Evaluation, Pfizer Global Research and Development, Ann Arbor, MI 48105
Eotaxin, which is a major mediator for eosinophil recruitment into
lung, has regulatory effects on neutrophil-dependent acute inflammatory
injury triggered by intrapulmonary deposition of IgG immune complexes
in rats. In this model, eotaxin mRNA and protein were up-regulated
during the inflammatory response, resulting in eotaxin protein
expression in alveolar macrophages and in alveolar epithelial cells.
Ab-induced blockade of eotaxin in vivo caused enhanced NF-
B
activation in lung, substantial increases in bronchoalveolar
lavage levels of macrophage inflammatory protein (MIP)-2 and
cytokine-induced neutrophil chemoattractant (CINC), and increased MIP-2
and CINC mRNA expression in alveolar macrophages. In contrast, TNF-
levels were unaffected, and IL-10 levels fell. Under these experimental
conditions, lung neutrophil accumulation was significantly increased,
and vascular injury, as reflected by extravascular leak of
125I-albumin, was enhanced. Conversely, when recombinant
eotaxin was administered in the same inflammatory model of lung injury,
bronchoalveolar lavage levels of MIP-2 were reduced, as was neutrophil
accumulation and the intensity of lung injury. In vitro stimulation of
rat alveolar macrophages with IgG immune complexes greatly increased
expression of mRNA and protein for MIP-2, CINC, MIP-1
, MIP-1
,
TNF-
, and IL-1
. In the copresence of eotaxin, the increased
levels of MIP-2 and CINC mRNAs were markedly diminished, whereas
MIP-1
, MIP-1
, TNF-
, and IL-1
expression of mRNA and protein
was not affected. These data suggest that endogenous eotaxin, which is
expressed during the acute lung inflammatory response, plays a
regulatory role in neutrophil recruitment into lung and the ensuing
inflammatory damage.
This article has been cited by other articles:
![]() |
F. Huaux, M. Gharaee-Kermani, T. Liu, V. Morel, B. McGarry, M. Ullenbruch, S. L. Kunkel, J. Wang, Z. Xing, and S. H. Phan Role of Eotaxin-1 (CCL11) and CC Chemokine Receptor 3 (CCR3) in Bleomycin-Induced Lung Injury and Fibrosis Am. J. Pathol., December 1, 2005; 167(6): 1485 - 1496. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Speyer, N. J. Rancilio, S. D. McClintock, J. D. Crawford, H. Gao, J. V. Sarma, and P. A. Ward Regulatory effects of estrogen on acute lung inflammation in mice Am J Physiol Cell Physiol, April 1, 2005; 288(4): C881 - C890. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Cheng, N. W. Lukacs, and S. L. Kunkel Eotaxin/CCL11 Suppresses IL-8/CXCL8 Secretion from Human Dermal Microvascular Endothelial Cells J. Immunol., March 15, 2002; 168(6): 2887 - 2894. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |